Enzymes associated with reductive activation and action of nitazoxanide, nitrofurans, and metronidazole in Helicobacter pylori
- PMID: 12069963
- PMCID: PMC127316
- DOI: 10.1128/AAC.46.7.2116-2123.2002
Enzymes associated with reductive activation and action of nitazoxanide, nitrofurans, and metronidazole in Helicobacter pylori
Abstract
Nitazoxanide (NTZ) is a redox-active nitrothiazolyl-salicylamide prodrug that kills Helicobacter pylori and also many anaerobic bacterial, protozoan, and helminthic species. Here we describe development and use of a spectrophotometric assay, based on nitroreduction of NTZ at 412 nm, to identify H. pylori enzymes responsible for its activation and mode of action. Three enzymes that reduce NTZ were identified: two related NADPH nitroreductases, which also mediate susceptibility to metronidazole (MTZ) (RdxA and FrxA), and pyruvate oxidoreductase (POR). Recombinant His-tagged RdxA, FrxA, and POR, overexpressed in nitroreductase-deficient Escherichia coli, each rapidly reduced NTZ, whereas only FrxA and to a lesser extent POR reduced nitrofuran substrates (furazolidone, nitrofurantoin, and nitrofurazone). POR exhibited no MTZ reductase activity either in extracts of H. pylori or following overexpression in E. coli; RdxA exhibited no nitrofuran reductase activity, and FrxA exhibited no MTZ reductase activity. Analysis of mutation to rifampin resistance (Rif(r)) indicated that NTZ was not mutagenic and that nitrofurans were only weakly mutagenic. Alkaline gel DNA electrophoresis indicated that none of these prodrugs caused DNA breakage. In contrast, MTZ caused DNA damage and was strongly mutagenic. We conclude that POR, an essential enzyme, is responsible for most or all of the bactericidal effects of NTZ against H. pylori. While loss-of-function mutations in rdxA and frxA produce a Mtz(r) phenotype, they do not contribute much to the innate susceptibility of H. pylori to NTZ or nitrofurans.
Figures




Similar articles
-
Characterization of the NAD(P)H oxidase and metronidazole reductase activities of the RdxA nitroreductase of Helicobacter pylori.FEBS J. 2009 Jun;276(12):3354-64. doi: 10.1111/j.1742-4658.2009.07060.x. Epub 2009 May 7. FEBS J. 2009. PMID: 19438716 Free PMC article.
-
Sequential inactivation of rdxA (HP0954) and frxA (HP0642) nitroreductase genes causes moderate and high-level metronidazole resistance in Helicobacter pylori.J Bacteriol. 2000 Sep;182(18):5082-90. doi: 10.1128/JB.182.18.5082-5090.2000. J Bacteriol. 2000. PMID: 10960091 Free PMC article.
-
Characterization of the genes rdxA and frxA involved in metronidazole resistance in Helicobacter pylori.Res Microbiol. 2003 Mar;154(2):137-44. doi: 10.1016/S0923-2508(03)00030-5. Res Microbiol. 2003. PMID: 12648728 Clinical Trial.
-
Metronidazole resistance in Helicobacter pylori.Int J Antimicrob Agents. 2002 Jan;19(1):1-7. doi: 10.1016/s0924-8579(01)00468-x. Int J Antimicrob Agents. 2002. PMID: 11814762 Review.
-
Mechanism and clinical significance of metronidazole resistance in Helicobacter pylori.Scand J Gastroenterol Suppl. 2001;(234):10-4. doi: 10.1080/003655201753265055. Scand J Gastroenterol Suppl. 2001. PMID: 11768554 Review.
Cited by
-
A c-Myc activation sensor-based high-throughput drug screening identifies an antineoplastic effect of nitazoxanide.Mol Cancer Ther. 2013 Sep;12(9):1896-905. doi: 10.1158/1535-7163.MCT-12-1243. Epub 2013 Jul 3. Mol Cancer Ther. 2013. PMID: 23825064 Free PMC article.
-
Synthesis and Antimicrobial Evaluation of Amixicile-Based Inhibitors of the Pyruvate-Ferredoxin Oxidoreductases of Anaerobic Bacteria and Epsilonproteobacteria.Antimicrob Agents Chemother. 2016 Jun 20;60(7):3980-7. doi: 10.1128/AAC.00670-16. Print 2016 Jul. Antimicrob Agents Chemother. 2016. PMID: 27090174 Free PMC article.
-
The Integrity of Heme Is Essential for Reproducible Detection of Metronidazole-Resistant Clostridioides difficile by Agar Dilution Susceptibility Tests.J Clin Microbiol. 2021 Aug 18;59(9):e0058521. doi: 10.1128/JCM.00585-21. Epub 2021 Aug 18. J Clin Microbiol. 2021. PMID: 34132582 Free PMC article.
-
Addition of Nitazoxanide to Standard Clarithromycin Based Triple Therapy for 2 Weeks Effectively Eradicates Treatment-Naive Helicobacter Pylori Infection. A Single Centre prospective, open-label study.Middle East J Dig Dis. 2022 Jan;14(1):77-84. doi: 10.34172/mejdd.2022.259. Epub 2022 Jan 30. Middle East J Dig Dis. 2022. PMID: 36619726 Free PMC article.
-
Nitazoxanide inhibits biofilm formation by Staphylococcus epidermidis by blocking accumulation on surfaces.Antimicrob Agents Chemother. 2010 Jul;54(7):2767-74. doi: 10.1128/AAC.00901-09. Epub 2010 Apr 19. Antimicrob Agents Chemother. 2010. PMID: 20404119 Free PMC article.
References
-
- Broekhuysen, J., A. Stockis, R. L. Lins, J. De Graeve, and J. F. Rossignol. 2000. Nitazoxanide: pharmacokinetics and metabolism in man. Int. J. Clin. Pharmacol. Ther. 38:387-394. - PubMed
-
- Bryant, C., and M. DeLuca. 1991. Purification and characterization of an oxygen-insensitive NAD(P)H nitroreductase from Enterobacter cloacae. J. Biol. Chem. 266:4119-4125. - PubMed
-
- Chalker, A. F., H. W. Minehart, N. J. Hughes, K. K. Koretke, M. A. Lonetto, K. K. Brinkman, P. V. Warren, A. Lupas, M. J. Stanhope, J. R. Brown, and P. S. Hoffman. 2001. Systematic identification of selective essential genes in Helicobacter pylori by genome prioritization and allelic replacement mutagenesis. J. Bacteriol. 183:1259-1268. - PMC - PubMed
-
- Doumbo, O., J. F. Rossignol, E. Pichard, H. A. Traore, T. M. Dembele, M. Diakite, F. Traore, and D. A. Diallo. 1997. Nitazoxanide in the treatment of cryptosporidial diarrhea and other intestinal parasitic infections associated with acquired immunodeficiency syndrome in tropical Africa. Am. J. Trop. Med. Hyg. 56:637-639. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources